Matches in Nanopublications for { ?s ?p "[Dihydropteroate synthase (H2Pte synthase) is the target of the sulfur-based antimalarial drugs, which are frequently used in synergistic combination with inhibitors of dihydrofolate reductase (H2folate reductase) to combat chloroquine-resistant malaria.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP279432.RAvsu6-DgZNTj9V6OEGrzqGcQDZG9nZxy3meIZ2-ySs1E130_assertion description "[Dihydropteroate synthase (H2Pte synthase) is the target of the sulfur-based antimalarial drugs, which are frequently used in synergistic combination with inhibitors of dihydrofolate reductase (H2folate reductase) to combat chloroquine-resistant malaria.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP279432.RAvsu6-DgZNTj9V6OEGrzqGcQDZG9nZxy3meIZ2-ySs1E130_provenance.
- NP1327182.RAlwH3q4VTFwWGQHXgqjwoqogG-BlaQJKQPnWH5n5eD4M130_assertion description "[Dihydropteroate synthase (H2Pte synthase) is the target of the sulfur-based antimalarial drugs, which are frequently used in synergistic combination with inhibitors of dihydrofolate reductase (H2folate reductase) to combat chloroquine-resistant malaria.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1327182.RAlwH3q4VTFwWGQHXgqjwoqogG-BlaQJKQPnWH5n5eD4M130_provenance.